Search
Close this search box.
Search
Close this search box.

Press Releases

Innova Medical Group Gifts £10m To Launch Global Pandemic Institute In Liverpool

– Liverpool is to headquarter the Pandemic Institute, which will provide the world’s first unique and comprehensive capability to predict, prevent, respond to and recover from Future Pandemics – Innova has provided the capital required to establish the Institute, alongside support from the Liverpool City Council, The University of Liverpool, Liverpool John

Adagio Therapeutics annonce l’élargissement de la population de patients participant à l’essai clinique mondial de phase 2/3 de l’ADG20 pour la prévention de la COVID-19

Le Comité de surveillance des données indépendant approuve l’élargissement aux adolescents ainsi qu’aux femmes enceintes et allaitantes sur la base des données d’innocuité et de tolérance de la partie de pré-inclusion de phase 2 WALTHAM, Massachusetts, 10 sept. 2021 (GLOBE NEWSWIRE) — Adagio Therapeutics, Inc., une société biopharmaceutique au stade

Adagio Therapeutics Anuncia Expansão da População de Pacientes no Ensaio Clínico Global de Fase 2/3 do ADG20 para Prevenção da COVID-19

Comitê Independente de Monitoramento de Dados Apoia a Expansão para Adolescentes e Gestantes e Mulheres Amamentando com Base em Dados de Segurança e Tolerabilidade da Fase 2 de Lead-In WALTHAM, Mass., Sept. 10, 2021 (GLOBE NEWSWIRE) — A Adagio Therapeutics, Inc., uma empresa biofarmacêutica de estágio clínico focada na descoberta,

Olives and Wine: Conagen Makes Accessible Antioxidant Hydroxytyrosol by Fermentation

Bedford, Mass., Sept. 10, 2021 (GLOBE NEWSWIRE) — Leveraging its robust phenolics platform, Conagen announced the expansion of the health ingredient portfolio of its commercial partner Blue California, with the successful scale-up and commercialization of the powerful natural antioxidant ingredient hydroxytyrosol.With its health-promoting properties, hydroxytyrosol is a phenylethanoid found in

Adagio Therapeutics Announces Expansion of Patient Population in Global Phase 2/3 Clinical Trial of ADG20 for the Prevention of COVID-19

Independent Data Monitoring Committee Supports Expansion to Adolescents and Pregnant and Nursing Women Based on Safety and Tolerability Data from Phase 2 Lead-In WALTHAM, Mass., Sept. 10, 2021 (GLOBE NEWSWIRE) — Adagio Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of antibody-based solutions for infectious

Disruptive.Asia constate que les fabricants chinois de puces tirent parti de l’innovation et de l’appui aux politiques pour atteindre la maturité en 14 nm

LONDRES, 10 septembre 2021 /PRNewswire/ — Disruptive.Asia constate que la quête d’autosuffisance de la Chine en matière de fabrication de puces permet non seulement de doper les capacités de fabrication de puces de 14 nm en vue de leur pleine maturité, mais aussi de positionner le pays comme un partenaire mondial clé dans